Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 12-Week play program boost development in At-Risk infants?

NCT ID NCT07716072

Not yet recruiting Disease control Sponsor: Nanyang Technological University Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests a 12-week home-based program called SPRINT for infants aged 7-15 months who were born preterm or have a family history of conditions like ADHD, autism, or developmental delay. Parents use an app to guide daily play activities aimed at improving parenting skills and the child's thinking and emotional development. The study compares families who receive the program immediately with those on a waitlist to see if the intervention leads to better outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 12-week home-based, parent-delivered program called SPRINT, delivered via an app with six modules focusing on awareness, bonding, cognition, decoding, emotions, and fun
What this could lead to
If successful, this program could offer a low-cost, scalable way to support early development in at-risk infants and reduce the impact of neurodevelopmental conditions.
What could go wrong
This is an early-stage trial with a small sample size, and the intervention relies on parent engagement, which may vary. Results may not generalize to all families.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder autism spectrum disorder Emotional Regulation global developmental delay with or without impaired intellectual development learning disability Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) AUTISM SPECTRUM DISORDER GLOBAL DEVELOPMENTAL DELAY PREMATURE BIRTH

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • NTU EMPOWER Centre

    Singapore, 308232, Singapore

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.